Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.

Revenue
+8.74%
EPS
−100.0%
Free cash flow
−0.54%
Total debt
−0.55%

Quarter to June 2026, against a year earlier

76.45 0.86 −1.11%
Market cap
$36.9B
P/E
58.4×
Fwd P/E
44.5×
Dividend yield
0.46%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100

Alcon (ALC) Current ratio

Alert me on Current ratio

Alcon's current ratio at the end of the quarter to 30 June 2026 was 2.1×, down 0.0× from fiscal 2025 (2.1×). Over the past ten years it has ranged from 1.8× (fiscal 2018) to 2.8× (fiscal 2024); the current reading is higher than 60% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 2.1× (23.63%)
FY2024 2.8× 17.61%
FY2023 2.4× 24.16%
FY2022 1.9× (12.95%)
FY2021 2.2× (1.35%)
FY2020 2.2× 19.92%
FY2019 1.8× 2.57%
FY2018 1.8× (2.85%)
FY2017 1.8× 1.93%
FY2016 1.8× —

Quarterly newest first

Period Current ratio Change
Jun 2026 2.1× (5.09%)
Mar 2026 2.2× 4.19%
Dec 2025 2.1× (0.14%)
Sep 2025 2.1× (18.58%)
26 more quarters

Against its own ten years

Low 1.8× High 2.8×
Ten-year median 2.0×
Current reading's percentile 60

Current ratio against peers

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on ALC